Ovid Therapeutics Income Statement (2020-2025) | OVID

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 6.91M5.70M208.38M221.00M0.90M0.01M222.50M0.07M0.07M0.11M222.80M0.15M0.17M0.17M0.13M6.27M0.13M
Operating items
Research & Development 14.63M16.03M15.88M16.88M16.25M7.68M4.92M18.09M7.83M6.05M5.18M5.56M6.62M6.00M5.33M10.64M10.40M12.58M7.86M5.92M6.66M6.46M5.87M
Selling, General & Administrative 5.67M7.11M7.44M10.41M15.58M6.63M6.76M8.26M9.88M8.26M7.63M6.66M8.34M8.25M6.80M7.69M7.17M8.10M5.54M4.88M6.02M4.88M6.79M
Other Operating Expenses 0.26M0.59M-0.02M-0.44M-0.05M-0.00M0.00M0.00M0.21M-0.28M0.84M-0.00M
Operating Expenses 20.29M23.14M23.32M27.29M31.83M14.31M11.68M26.35M17.71M14.30M12.81M12.22M14.96M14.25M12.14M18.33M17.57M20.69M13.40M10.80M12.68M11.35M12.65M
Operating Income -20.29M-23.14M-16.40M-21.59M176.56M-14.31M-11.68M-26.35M-16.27M-14.30M-12.80M-12.17M-14.89M-14.17M-12.03M-18.19M-17.42M-20.52M-13.23M-10.72M-12.55M-5.07M-12.52M
EBIT -20.29M-23.14M-16.40M-21.59M176.56M-14.31M-11.68M-26.35M-16.27M-14.30M-12.80M-12.17M-14.89M-14.17M-12.03M-18.19M-17.42M-20.52M-13.23M-10.72M-12.55M-5.07M-12.52M
Non-operating items
Other Non Operating Income 0.21M-0.28M0.84M0.67M1.54M1.76M0.78M2.87M5.72M29.04M-0.78M1.47M2.31M0.39M0.36M
Non Operating Income 0.21M-0.28M0.84M0.67M1.54M1.76M0.78M2.87M5.72M29.04M-0.78M1.47M2.31M0.39M0.36M
Net income details
EBT -20.03M-22.55M-16.42M-22.03M176.51M-14.32M-11.68M-26.35M-16.06M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.68M-12.16M
Tax Provisions 0.50M1.47M-0.29M-0.35M0.05M
Profit After Tax -20.03M-22.55M-16.42M-22.03M176.01M-15.79M-11.38M-26.00M-16.11M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.70M-12.20M
Income from Continuing Operations -20.03M-22.55M-16.42M-22.03M176.01M-15.79M-11.38M-26.00M-16.11M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.68M-12.16M
Consolidated Net Income -20.03M-22.55M-16.42M-22.03M176.01M-15.79M-11.38M-26.00M-16.11M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.68M-12.16M
Income towards Parent Company -20.03M-22.55M-16.42M-22.03M176.01M-15.79M-11.38M-26.00M-16.11M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.68M-12.16M
Net Income towards Common Stockholders -20.03M-22.55M-16.42M-22.03M176.01M-15.79M-11.38M-26.00M-16.11M-14.59M-11.97M-11.50M-13.36M-12.41M-11.25M-15.32M-11.69M8.52M-14.01M-9.25M-10.23M-4.68M-12.16M
Additional items
EPS (Basic) -0.37-0.41-0.28-0.382.55-0.23-0.17-0.37-0.23-0.21-0.17-0.16-0.19-0.18-0.16-728.12-162.50118.07-193.92-0.13-141.57-64.73-168.01
EPS (Weighted Average and Diluted) -0.37-0.41-0.28-0.382.53-0.23-0.17-0.38-0.23-0.21-0.17-0.16-0.19-0.18-0.16-728.12-162.50117.61-193.92-0.13-141.57-64.73-168.01
Shares Outstanding (Weighted Average) 54.72M55.61M59.41M58.45M66.09M67.82M67.93M67.48M70.35M70.39M70.43M70.42M70.49M70.53M70.62M70.58M70.72M70.92M70.98M70.91M71.05M71.11M71.11M
Shares Outstanding (Diluted Average) 58.45M66.58M67.82M67.93M68.07M70.35M70.39M70.43M70.42M70.49M70.53M70.62M70.58M70.72M71.20M70.98M70.91M71.05M71.11M71.11M
EBITDA -20.29M-23.14M-16.40M-21.59M176.56M-14.31M-11.68M-26.35M-16.27M-14.30M-12.80M-12.17M-14.89M-14.17M-12.03M-18.19M-17.42M-20.52M-13.23M-10.72M-12.55M-5.07M-12.52M
Tax Rate 0.28%-10.29%2.52%1.33%-0.31%